Progress
Quantity
23600
Organization Name Not Disclosed seeks supply of medicines with specified dosage form, strength, and compliant primary packaging. The scope includes ensuring a valid drug manufacturing license under the Drugs & Cosmetic Act, shelf life from manufacture, and certificates of analysis. The contract allows a 25% quantity variation and a maximum delivery window of 45 days. Bid submission requires regulatory certifications, Make in India and MSME considerations, and GST-compliant invoicing. This procurement emphasizes pharmacopoeia compliance (USP/BP/EP) and rigorous supplier documentation, aiming to secure high-quality pharmaceutical products for delivery and inspection at receipt.
Medicine name alignment with cataloged items
Dosage form and strength clearly specified
Primary packing type and size (tablets per strip/blister)
Shelf life in months from manufacture date
Valid drug manufacturing license under Drugs and Cosmetic Act
Pharmacopoeia standards compliance (USP/BP/EP)
Certificates of analysis for each batch and test reports
Delivery window capped at 45 days; 25% quantity variation allowed
GST invoice and GST portal payment proof required for invoicing
Compliance with pharmacopoeia standards; license and C/o A for each batch
Make in India and MSME considerations; OEM authorisation where applicable
GST-compliant invoicing on GeM; payment terms aligned to delivery milestones per contract; verify GST portal payment confirmation
Maximum 45 days from order date; option to extend with percentage-based quantity adjustments as per clause
Not explicitly listed; adherence to delivery and quality acceptance implied; rejection for non-conforming items
Demonstrated experience supplying pharmaceutical products under Drugs & Cosmetic Act
Valid drug manufacturing license and QA certificates for batch release
GST registration and compliance with GST invoicing on GeM
Main Document
CATALOG Specification
CATALOG Specification
CATALOG Specification
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS
| Category | Specification | Requirement |
|---|---|---|
| PRODUCT INFORMATION | Medicine Name | Hydrocortisone |
| PRODUCT INFORMATION | Dosage Form | Powder for Injection |
| PRODUCT INFORMATION | Strength | 100 mg |
| PRODUCT INFORMATION | Compliance to uploaded Special Terms and Conditions | Yes |
| PACKAGING | Type of primary packing | Vial |
| PACKAGING | Primary pack size | Single Vial |
| CERTIFICATIONS & REPORTS | Availability of valid drug manufacturing license issued from the competent authority defined under Drugs and Cosmetic Act and Rules there under as amended till date | Yes |
| CERTIFICATIONS & REPORTS | Submission of all necessary certifications, licenses and test reports to the buyer as per buyer requirement at the time of bid submission and along with supplies | Yes |
| SHELF LIFE | Shelf life in months from the date of manufacture | 24, 36 Or higher |
Discover companies most likely to bid on this tender
GST registration certificate
PAN card
Experience certificates for pharmaceutical supply
Financial statements (as required)
Drug manufacturing license(s) under Drugs and Cosmetic Act
Certificates of analysis for supplied batches
OEM authorization or authorised distributor confirmation
Make in India certificate (if applicable)
MSME certificate (if applicable)
Shelf life statements and batch-release documentation
Key insights about KERALA tender market
To bid, ensure your organization holds a valid drug manufacturing license under the Drugs & Cosmetic Act, provides Certificates of Analysis, and negotiates packaging specs (primary packing type and size). Upload GST invoice proof and OEM authorisation if required. Prepare Make in India and MSME documentation, plus shelf-life compliance data.
Submit GST registration, PAN, drug manufacturing license, Certificates of Analysis, batch test reports, OEM authorization, Make in India and MSME certificates if applicable, shelf-life data, and financial statements. Provide bid-compliant packaging specifications and delivery capability for 45-day deliveries.
Specifications include exact medicine name, dosage form, strength, primary packing type and size, shelf life in months, and pharmacopoeia compliance (USP/BP/EP). Licenses and batch-wise certificates of analysis must accompany each supply; items will be inspected on delivery.
Delivery must be completed within 45 days. The purchaser may increase or decrease quantity up to 25% of the bid quantity at contract placement, with similar 25% adjustments during currency, subject to minimum 30 days after last delivery date.
Verify the drug manufacturing license under the Drugs & Cosmetic Act, ensure current validity, and attach Certificates of Analysis for each batch. OEM authorizations must be provided, and all items must meet USP/BP/EP pharmacopoeia standards before supply.
Submit GST-compliant invoices on the GeM portal, including a GST payment confirmation screenshot. Ensure the invoice reflects the awarded quantity, batch numbers, and shelf-life data. This is required for bid evaluation and payment processing.
Provide Make in India certificate and, if applicable, MSME certificate; include supplier registration and relevant endorsements. These documents support eligibility and may influence bid evaluation and preference handling according to buyer terms.
Items failing quality or specification checks will be rejected. The supplier must supply compliant replacements promptly; discrepancies trigger rejection and may impact payment and contract continuity, with potential penalties per governing terms.
Sign up now to access all documents
Main Document
CATALOG Specification
CATALOG Specification
CATALOG Specification
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS